Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
Research studies
Study commences on chronic disease caused by trauma
Research studies : 21 January, 2016
The detection and diagnosis of chronic traumatic encephalopathy associated with sports and military injuries is the subject of a new clinical study by Aethlon Medical
 
Extracting bioactive compounds from marine microalgae
Research studies : 29 December, 2014
Microalgae are photosynthetic microorganisms that produce high value compounds considered essential for human health, including polyunsatured fatty acids (eg omega-3s like EPA and DHA), various pigments (chlorophyll and carotenoids), and vitamins. Although fish have traditionally been our principal dietary source of EPA and DHA, declining marine fish stocks, the unpleasant odour of fish oil, and other disadvantages, have prompted a search for alternative sources of these nutrients.
 
Top 30 pharma companies spent $112 billion on research and development in 2013, says report
Research studies : 29 December, 2014
The world’s leading 30 pharmaceutical companies spent a combined $112 billion on research and development (R&D) in 2013, an increase of $723 million over the previous year, according to research and consulting firm GlobalData.
 
UK Government support for research into disease focuses on imaging techniques
Research studies : 26 October, 2014
The UK Chancellor of the Exchequer, George Osborne, has announced that a partnership led by the Medical Research Council (MRC) will invest over £230 million in a range of revolutionary technologies aimed at identifying the causes of diseases such as cancer and dementia, and dramatically speeding up diagnosis and treatment. The state-of-the-art technologies will be used to find out how differences in the cellular and molecular make-up of people affect how they respond to diseases and to treatment.
 
New methods enhance the quality of myocardial perfusion imaging
Research studies : 21 September, 2014
In a recent PhD study completed at the University of Eastern Finland, Tuija Kangasmaa, Lic. Phil, has invented a method which makes it possible to reduce the imaging time by up to 50%, making the scan session easier for the patient. Furthermore, the study also created two additional methods which correct errors resulting from patient movement during the scan. The methods were validated and they have already been taken into use in hospitals all over the world.
 
Research: human sweat can reduce bacteria defences in hospitals and schools
Research studies : 22 July, 2014
Sweaty hands can reduce the effectiveness of bacteria-fighting brass objects in hospitals and schools after just an hour of coming into contact with them, according to scientists at the University of Leicester; sweat can cause corrosion of protective qualities of door knobs and taps within an hour of contact.
 
Additional funding secured for breast cancer treatment programme
Research studies : 01 April, 2014
The Second engineered T Cell therapy programme for use in fighting breast cancer has been awarded over 2 million pounds in funding
 
Funding received for T Cell therapy programme
Research studies : 25 March, 2014
Over two million pounds in funding will help to advance breast cancer cell recognition through second engineered T Cell therapy
 
Researchers make inroads in early cancer detection
Research studies : 21 March, 2014
Aethlon Medical expands brain research discoveries to include isolation of glioblastoma biomarker and therapeutic target
 
Researchers pioneer prevention of neonatal disability in twins
Research studies : 12 March, 2014
The University of Birmingham has undertaken successful research in reducing disabilities in neonatal twins due to twin-twin transfusion syndrome
 
Clinical research company to attend virology event
Research studies : 10 March, 2014
Retroscreen virology is attending a respiratory viral infection symposium taking place this month in South Korea
 
Virology researchers to attend BioLeaders Forum
Research studies : 14 January, 2014
Research company Retroscreen Virology is taking part in a forum for experts to share their knowledge on vaccines and immunotherapy in Washington
 
Late stage melanoma treatment presentation at healthcare conference
Research studies : 14 January, 2014
Immunocore will be present at the JP Morgan Healthcare conference to discuss the treatment of late stage melanoma
 
Market of kidney and urinary devices examined
Research studies : 13 January, 2014
Report from Research and Markets examines the industry potential for nephrology and urology devices to 2018
 
Immunotherapy research partnership agreement
Research studies : 09 January, 2014
Immunocore and MedImmune have reached an agreement to collaborate on the research of immunotherapy for the treatment of cancer
 
Technical insights into organ regeneration and tissue engineering
Research studies : 08 January, 2014
Report provides insight into the current state of tissue engineering and organ regeneration in biomedical engineering
 
Encouraging T Cell targeting antigen trial results
Research studies : 11 December, 2013
Interim results have been presented from engineered T cell trials which target cancer testis antigens in multiple myeloma
 
Nanofibres help in targeting fungal infections
Research studies : 10 December, 2013
New material breakthrough involving biocompatible nanofibres provides hope in the relief of fungal infections
 
New Chairman appointed at T cell therapy company
Research studies : 02 December, 2013
T cell receptor engineering technology company appoints new Chairman to the Board of Directors
 
Brain injury effects on pituitary hormone
Research studies : 26 September, 2013
Researchers have been examining the effects of traumatic brain injuries caused by explosions on the pituitary hormones of soldiers
 
Nanoparticles deliver vaccines directly to mucosal surfaces
Research studies : 26 September, 2013
MIT research develops nanoparticle that stays on lung surface long enough to generate strong immune response to prevent infections
 
Healthcare staffing models examined in research
Research studies : 12 September, 2013
First stage in research published on healthcare staffing models in cooperation with the North West Workforce Modernisation Hub
 
MIT researchers work out why gold nanoparticles can penetrate cell walls
Research studies : 23 August, 2013
Cells are good at protecting their precious contents - and as a result, it's difficult to penetrate their membrane walls to deliver drugs, nutrients or biosensors without damaging or destroying the cell.
 
Ariosa Diagnostics, CHU de Quebec and Genome Canada launch study of non-invasive prenatal testing in Canada
Research studies : 14 August, 2013
A team of researchers led by CHU de Quebec and Universite Laval, has received CAN$10.5 million from Genome Canada, the Canadian Institutes of Health Research (CIHR), Genome Quebec and other partners to conduct a large-scale comparative effectiveness study on non-invasive prenatal screening techniques.
 
Mechanism offers fresh approach for harnessing the immune system to fight cancer
Research studies : 05 August, 2013
St Jude Children's Research Hospital scientists discover a way to target the immune system to shrink or eliminate tumours in mice without causing autoimmune problems.
 
St Jude Medical starts landmark study of renal denervation for reduction of heart attack, stroke and death
Research studies : 18 February, 2013
St Jude Medical is planning a new landmark study that will evaluate whether renal denervation and medication can provide health benefits to patients beyond lowering high blood pressure.
 
Cook Medical passes 50 percent enrollment in study of technique for treating critical limb ischemia
Research studies : 07 February, 2013
With more than 100 patients enrolled, Cook Medical exceeds 50 percent enrollment in the Tibiopedal Access for Crossing of Infrainguinal Artery Occlusions trial.
 
Study into home monitoring for CF patients is expanded
Research studies : 05 February, 2013
ERT together with pulmonary researchers at the Johns Hopkins University School of Medicine and University of Washington, are expanding the Early Intervention in Cystic Fibrosis Exacerbation (eICE) Study.
 
Diamyd's diabetes vaccine to undergo clinical study
Research studies : 04 February, 2013
Diamyd Medical is reporting that a new clinical study with the diabetes vaccine Diamyd is planned to start in February 2013.
 
Gene sequencing project mines junk DNA data for cancer treatment clues
Research studies : 29 January, 2013
St Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project, develops an approach to mine the repetitive segments of DNA at the ends of chromosomes for insights into cancer.
 
MIT deforms cells to deliver RNA, proteins and nanoparticles for many applications
Research studies : 25 January, 2013
Researchers from MIT discover a safe and efficient way to get large molecules through the cell membrane, by squeezing the cells through a narrow constriction that opens up tiny, temporary holes in the membrane.
 
Global paediatric Phase III pivotal study of recombinant fusion protein begins enrollment
Research studies : 24 January, 2013
CSL Behring reports that the first patient is now enrolled in the pivotal paediatric phase III study to evaluate the safety, efficacy and pharmacokinetics of recombinant fusion protein linking coagulation factor IX with recombinant albumin (rIX-FP) in previously treated children (up to age 11 years).
 
Genetic basis of high-risk childhood cancer shows the way to new drug treatment strategies
Research studies : 22 January, 2013
Research led by St Jude Children's Research Hospital scientists identifies a possible lead in treatment of two childhood leukaemia subtypes known for their loss of chromosomes and poor treatment outcomes.
 
Study shows stereotactic radiosurgery is promising for kidney cancer
Research studies : 02 November, 2012
A first-of-its-kind clinical trial conducted at University Hospitals (UH) Case Medical Center Seidman Cancer Center is showing encouraging results for the use of stereotactic radiosurgery to treat kidney cancer.
 
Improved diagnostic test identifies treatment for children with acute myeloid leukemia
Research studies : 11 September, 2012
Research led by St Jude Children's Research Hospital investigators has identified the best test for measuring early treatment response for young patients with acute myeloid leukemia (AML).
 
Neuralstem completes Phase I ALS stem cell trial
Research studies : 29 August, 2012
Neuralstem completes the Phase I trial of its NSI-566 spinal cord neural stem cells for the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease), with the eighteenth patient treated.
 
Age of father is found to more critical to new mutations being passed to offspring
Research studies : 24 August, 2012
deCODE Genetics in collaboration with Illumina reports in the journal Nature that a father's age, not a mother's, at the time a child is conceived is the single largest contributor to the passing of new hereditary mutations to offspring.
 
Research shows success of engineered tissue depends on where it is grown
Research studies : 15 August, 2012
MIT researchers led by Elazer Edelman, the Thomas D and Virginia W Cabot Professor of Health Sciences and Technology, are showing that implanted cells' therapeutic properties depend on their shape, which is determined by the type of scaffold on which they are grown. The work could allow scientists to develop even more effective implants and also target many other diseases, including cancer.
 
Quotient completes a programme to develop an optimised drug for new pain medication
Research studies : 25 July, 2012
Quotient Clinical is reporting the publication of results, in the journal Pharmaceutical Research, of a RapidFACT programme conducted for Eli Lilly.
 
Nordion plans Europe-focused Phase III clinical trial for liver cancer treatment
Research studies : 25 April, 2012
Nordion is supporting an additional randomized, multi-centre Phase III clinical trial for TheraSphere, Nordion's yttrium-90 (Y-90) glass microsphere treatment for liver cancer.
 
Largest Warfarin patient self-testing study points to new standard of care
Research studies : 29 March, 2012
Alere reveals at the 2012 American College of Cardiology Summit the results from the world's largest study of warfarin (Coumadin) patient self-testers, performed by anticoagulation expert, Jack Ansell, MD, which showed that self-testing led to excellent therapy control.
 
Study finds chronic pain patients benefit from education
Research studies : 28 February, 2012
A study conducted at Mayo Pain Rehabilitation Center, Rochester, Maine, USA by Sarah Hayes and Michael Hooten, MD, Associate Professor of Anesthesiology at Mayo Clinic shows that substance use education incorporated into a cognitive behavioural rehabilitation programming is effective to improve pain and function for the chronic pain patient at high-risk for comorbid substance abuse.
 
Sequencing project links mutations with childhood brain tumours
Research studies : 01 February, 2012
Researchers at St Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project provides first evidence linking cancer to mutations in genes involved in DNA organization.
 
New indicator selects patients with increased throat cancer risk
Research studies : 17 January, 2012
Researchers at the University of Michigan Health System discover a new indicator that may predict which patients with a common type of throat cancer are most likely have the cancer spread to other parts of their bodies.
 
Cancer research study to target tumour-secreted exosomes
Research studies : 07 December, 2011
Aethlon Medical is reporting that a cancer research study to test the ex vivo effectiveness of the Aethlon Hemopurifier to capture tumour-secreted exosomes from the blood of advanced-stage cancer patients has received institutional review board approval to begin studies at the Sarcoma Oncology Center, based in Santa Monica, California, USA.
 
Research on dendrites clinches 2011 Eppendorf and Science Prize
Research studies : 17 November, 2011
The Portuguese scientist, Tiago Branco MD, PhD, Postdoctoral Research Fellow at University College London is named the winner of the 2011 Eppendorf and Science Prize for Neurobiology for his research on dendrites.
 
FDA gives Neuralstem approval to dose in cervical region in ALS trial
Research studies : 26 October, 2011
Neuralstem is updating the progress of its ongoing Phase I safety trial of the company's spinal cord stem cells in the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) at Emory University in Atlanta, Georgia, USA.
 
Personalized medicine study yields clues about patient engagement
Research studies : 18 October, 2011
The Medco Research Institute, the research subsidiary of Medco Health Solutions, and Quest Diagnostics are reporting their study showed a statistically significant increase in adherence to statin therapy over six months in patients receiving kinesin-like protein 6 (KIF6) gene testing, compared with those who did not.
 
Two rare genetic variants pinpoint risk of gout
Research studies : 11 October, 2011
Scientists at deCODE Genetics and academic collaborators from Iceland, Norway, Denmark, the Netherlands and the USA are reporting the discovery of low frequency variants in the human genome that associate with risk of gout, a common inflammatory arthritis, and serum uric acid levels.
 
Genetic risk factor for skin, prostate and brain cancers is identified
Research studies : 27 September, 2011
Scientists at deCODE Genetics and academic collaborators from Iceland, The Netherlands, Spain, Denmark, Germany, Sweden, the USA, the UK and Romania are reporting the discovery of a variant in the sequence of the human genome associated with risk of developing basal cell carcinoma of the skin (BCC), as well as prostate cancer and glioma, the most serious form of brain cancer.
 
First | Prev  | 1 | 2 | 3  | Next  | Last
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo